Stocks and Investing
Stocks and Investing
Wed, October 26, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, October 25, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
David Amsellem Maintained (AMPH) at Buy with Decreased Target to $40 on, Oct 25th, 2022
David Amsellem of Piper Sandler, Maintained "Amphastar Pharmaceuticals, Inc." (AMPH) at Buy with Decreased Target from $43 to $40 on, Oct 25th, 2022.
David has made no other calls on AMPH in the last 4 months.
There are 2 other peers that have a rating on AMPH. Out of the 2 peers that are also analyzing AMPH, 0 agree with David's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with David
- Glen Santangelo of "Jefferies" Initiated at Strong Buy and Held Target at $36 on, Friday, October 21st, 2022
- Tim Chiang of "Capital One" Initiated at Buy and Held Target at $44 on, Friday, July 29th, 2022
Contributing Sources